BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9337227)

  • 1. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.
    Mosca L; Manson JE; Sutherland SE; Langer RD; Manolio T; Barrett-Connor E
    Circulation; 1997 Oct; 96(7):2468-82. PubMed ID: 9337227
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease in women.
    Eaker ED; Chesebro JH; Sacks FM; Wenger NK; Whisnant JP; Winston M
    Circulation; 1993 Oct; 88(4 Pt 1):1999-2009. PubMed ID: 8403349
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease is preventable among women.
    Kuller LH
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):175-87. PubMed ID: 20136604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in women: what's different? What's new? What's unresolved?
    Legato MJ
    Ann N Y Acad Sci; 1994 Dec; 736():147-57. PubMed ID: 7710201
    [No Abstract]   [Full Text] [Related]  

  • 6. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    El Khoudary SR; Aggarwal B; Beckie TM; Hodis HN; Johnson AE; Langer RD; Limacher MC; Manson JE; Stefanick ML; Allison MA;
    Circulation; 2020 Dec; 142(25):e506-e532. PubMed ID: 33251828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in women.
    Weiss AM
    Prim Care; 2009 Mar; 36(1):73-102, viii. PubMed ID: 19231603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
    Wenger NK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):118-9. PubMed ID: 20233978
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.
    Abramson BL;
    CMAJ; 2004 Apr; 170(9):1388-9. PubMed ID: 15111467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does hormone replacement therapy in menopause have a cardiovascular benefit?].
    Scarabin PY
    Rev Med Interne; 2003 Apr; 24(4):216-7. PubMed ID: 12706776
    [No Abstract]   [Full Text] [Related]  

  • 11. How the American Heart Association helped change women's heart health.
    Brown N
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S60-2. PubMed ID: 25714819
    [No Abstract]   [Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. Decline in deaths from heart disease and stroke--United States, 1900-1999.
    JAMA; 1999 Aug; 282(8):724-6. PubMed ID: 10463697
    [No Abstract]   [Full Text] [Related]  

  • 13. What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?
    Wenger NK
    Clin Cardiol; 2011 Sep; 34(9):520-3. PubMed ID: 21905040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.
    Humphrey LL; Chan BK; Sox HC
    Ann Intern Med; 2002 Aug; 137(4):273-84. PubMed ID: 12186518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's cardiovascular health: prevention is key.
    Oertelt-Prigione S; Regitz-Zagrosek V
    Arch Intern Med; 2009 Oct; 169(19):1740-1. PubMed ID: 19858428
    [No Abstract]   [Full Text] [Related]  

  • 16. Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
    Langer RD; Simon JA; Pines A; Lobo RA; Hodis HN; Pickar JH; Archer DF; Sarrel PM; Utian WH
    Climacteric; 2017 Oct; 20(5):402-413. PubMed ID: 28805475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana.
    Orchard TJ; Strandness DE
    Diabetes Care; 1993 Aug; 16(8):1199-209. PubMed ID: 8375253
    [No Abstract]   [Full Text] [Related]  

  • 18. Notes From Cardiology Clinic: Woman, Lost During Follow-up.
    Waters DD
    Can J Cardiol; 2019 Nov; 35(11):1435-1436. PubMed ID: 31542256
    [No Abstract]   [Full Text] [Related]  

  • 19. Representation of women in randomized clinical trials of cardiovascular disease prevention.
    Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for the primary prevention of cardiovascular disease in women?
    Birge SJ
    Menopause; 2012 Dec; 19(12):1287-8. PubMed ID: 23187611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.